Results
|
17501.
|
|
|
17502.
|
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease. [electronic resource] by
- Roberts, Andrew W
- Seymour, John F
- Brown, Jennifer R
- Wierda, William G
- Kipps, Thomas J
- Khaw, Seong Lin
- Carney, Dennis A
- He, Simon Z
- Huang, David C S
- Xiong, Hao
- Cui, Yue
- Busman, Todd A
- McKeegan, Evelyn M
- Krivoshik, Andrew P
- Enschede, Sari H
- Humerickhouse, Rod
Producer: 20120330
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|
|
17503.
|
|
|
17504.
|
|
|
17505.
|
|
|
17506.
|
|
|
17507.
|
Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance. [electronic resource] by
- Zhang, Min
- Fu, Wuxia
- Prabhu, Sharmila
- Moore, James C
- Ko, Je
- Kim, Jung Woo
- Druker, Brian J
- Trapp, Valerie
- Fruehauf, John
- Gram, Hermann
- Fan, Hung Y
- Ong, S Tiong
Producer: 20081024
In:
Molecular and cellular biology vol. 28
Availability: No items available.
|
|
17508.
|
|
|
17509.
|
|
|
17510.
|
Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas. [electronic resource] by
- Sumi, Toshiyuki
- Hirai, Sachie
- Yamaguchi, Miki
- Tanaka, Yusuke
- Tada, Makoto
- Yamada, Gen
- Hasegawa, Tadashi
- Miyagi, Yohei
- Niki, Toshiro
- Watanabe, Atsushi
- Takahashi, Hiroki
- Sakuma, Yuji
Producer: 20181002
In:
International journal of oncology vol. 53
Availability: No items available.
|
|
17511.
|
|
|
17512.
|
|
|
17513.
|
|
|
17514.
|
|
|
17515.
|
Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo. [electronic resource] by
- Chen, Zhen
- Chen, Yifan
- Xu, Meng
- Chen, Likun
- Zhang, Xu
- To, Kenneth Kin Wah
- Zhao, Hongyun
- Wang, Fang
- Xia, Zhongjun
- Chen, Xiaoqin
- Fu, Liwu
Producer: 20170629
In:
Molecular cancer therapeutics vol. 15
Availability: No items available.
|
|
17516.
|
|
|
17517.
|
|
|
17518.
|
|
|
17519.
|
Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties. [electronic resource] by
- Hegedus, C
- Ozvegy-Laczka, C
- Apáti, A
- Magócsi, M
- Német, K
- Orfi, L
- Kéri, G
- Katona, M
- Takáts, Z
- Váradi, A
- Szakács, G
- Sarkadi, B
Producer: 20100119
In:
British journal of pharmacology vol. 158
Availability: No items available.
|
|
17520.
|
|